IL-13 Targeting Biologics for the Treatment of Atopic Dermatitis - Episode 10
Switching or Staying Within the Treatment Class
Published on:
Panelists discuss when to consider switching to another biologic or exploring a different mechanism of action in atopic dermatitis treatment, focusing on factors like inadequate response, adverse effects, or the need for more targeted therapy to optimize patient outcomes.
Video content above is prompted by the following:
- Can you talk about when we should consider switching to another biologic or when to go with a different mechanism of action?
